These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 22560326)

  • 21. 15-Deoxy-Δ12,14-prostaglandin J2 enhanced the anti-tumor activity of camptothecin against renal cell carcinoma independently of topoisomerase-II and PPARγ pathways.
    Yamamoto Y; Fujita M; Koma H; Yamamori M; Nakamura T; Okamura N; Yagami T
    Biochem Biophys Res Commun; 2011 Jul; 410(3):563-7. PubMed ID: 21683069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autocrine activation of human monocyte/macrophages by monocyte-derived microparticles and modulation by PPARγ ligands.
    Bardelli C; Amoruso A; Federici Canova D; Fresu L; Balbo P; Neri T; Celi A; Brunelleschi S
    Br J Pharmacol; 2012 Feb; 165(3):716-28. PubMed ID: 21745193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 15-deoxy-Delta12,14-prostaglandin J2 inhibits INF-gamma-induced JAK/STAT1 signalling pathway activation and IP-10/CXCL10 expression in mesangial cells.
    Panzer U; Zahner G; Wienberg U; Steinmetz OM; Peters A; Turner JE; Paust HJ; Wolf G; Stahl RA; Schneider A
    Nephrol Dial Transplant; 2008 Dec; 23(12):3776-85. PubMed ID: 18596134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peroxisome proliferator-activated receptor-gamma ligands 15-deoxy-delta(12,14)-prostaglandin J2 and pioglitazone inhibit hydroxyl peroxide-induced TNF-alpha and lipopolysaccharide-induced CXC chemokine expression in neonatal rat cardiac myocytes.
    Liu J; Xia Q; Zhang Q; Li H; Zhang J; Li A; Xiu R
    Shock; 2009 Sep; 32(3):317-24. PubMed ID: 19174742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 15d-prostaglandin J2 inhibits inflammatory hypernociception: involvement of peripheral opioid receptor.
    Napimoga MH; Souza GR; Cunha TM; Ferrari LF; Clemente-Napimoga JT; Parada CA; Verri WA; Cunha FQ; Ferreira SH
    J Pharmacol Exp Ther; 2008 Jan; 324(1):313-21. PubMed ID: 17928570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 15-Deoxy-delta 12,14-prostaglandin J2 biphasically regulates the proliferation of mouse hippocampal neural progenitor cells by modulating the redox state.
    Katura T; Moriya T; Nakahata N
    Mol Pharmacol; 2010 Apr; 77(4):601-11. PubMed ID: 20086036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes.
    Yamamoto K; Ohki R; Lee RT; Ikeda U; Shimada K
    Circulation; 2001 Oct; 104(14):1670-5. PubMed ID: 11581147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PPAR-gamma ligands modulate effects of LPS in stimulated rat synovial fibroblasts.
    Simonin MA; Bordji K; Boyault S; Bianchi A; Gouze E; Bécuwe P; Dauça M; Netter P; Terlain B
    Am J Physiol Cell Physiol; 2002 Jan; 282(1):C125-33. PubMed ID: 11742805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
    Grau R; Iñiguez MA; Fresno M
    Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytotoxicity of 15-deoxy-Δ(12,14)-prostaglandin J(2) through PPARγ-independent pathway and the involvement of the JNK and Akt pathway in renal cell carcinoma.
    Fujita M; Tohji C; Honda Y; Yamamoto Y; Nakamura T; Yagami T; Yamamori M; Okamura N
    Int J Med Sci; 2012; 9(7):555-66. PubMed ID: 22991494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 15-Deoxy-Δ¹²,¹⁴-prostaglandin J₂-glycerol, a putative metabolite of 2-arachidonyl glycerol and a peroxisome proliferator-activated receptor γ ligand, modulates nuclear factor of activated T cells.
    Raman P; Kaplan BL; Kaminski NE
    J Pharmacol Exp Ther; 2012 Sep; 342(3):816-26. PubMed ID: 22700433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of peripheral kappa/delta opioid receptors mediates 15-deoxy-(Delta12,14)-prostaglandin J2 induced-antinociception in rat temporomandibular joint.
    Pena-dos-Santos DR; Severino FP; Pereira SA; Rodrigues DB; Cunha FQ; Vieira SM; Napimoga MH; Clemente-Napimoga JT
    Neuroscience; 2009 Nov; 163(4):1211-9. PubMed ID: 19647045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A PPAR-gamma ligand, 15-deoxy-Delta12,14-prostaglandin J(2), inhibited gastric mucosal injury induced by ischemia-reperfusion in rats.
    Takagi T; Naito Y; Ichikawa H; Tomatsuri N; Katada K; Isozaki Y; Kuroda M; Kokura S; Yoshida N; Yoshikawa T
    Redox Rep; 2004; 9(6):376-81. PubMed ID: 15720836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diverse cardioprotective signaling mechanisms of peroxisome proliferator-activated receptor-gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone, in reperfusion injury: role of nuclear factor-kappaB, heat shock factor 1, and Akt.
    Zingarelli B; Hake PW; Mangeshkar P; O'Connor M; Burroughs TJ; Piraino G; Denenberg A; Wong HR
    Shock; 2007 Nov; 28(5):554-63. PubMed ID: 17589386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects of peroxisome proliferator activated receptor-gamma (PPAR gamma) ligands in proximal tubular cells: thiazolidinediones are partial PPAR gamma agonists.
    Chana RS; Lewington AJ; Brunskill NJ
    Kidney Int; 2004 Jun; 65(6):2081-90. PubMed ID: 15149321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanomolar and micromolar effects of 15-deoxy-delta 12,14-prostaglandin J2 on amnion-derived WISH epithelial cells: differential roles of peroxisome proliferator-activated receptors gamma and delta and nuclear factor kappa B.
    Berry EB; Keelan JA; Helliwell RJ; Gilmour RS; Mitchell MD
    Mol Pharmacol; 2005 Jul; 68(1):169-78. PubMed ID: 15821150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of peroxisome proliferator-activated receptor gamma inhibits interleukin-1beta-induced membrane-associated prostaglandin E2 synthase-1 expression in human synovial fibroblasts by interfering with Egr-1.
    Cheng S; Afif H; Martel-Pelletier J; Pelletier JP; Li X; Farrajota K; Lavigne M; Fahmi H
    J Biol Chem; 2004 May; 279(21):22057-65. PubMed ID: 15023995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 15-Deoxy-Δ(12,14)-prostaglandin J(2) interferes inducible synthesis of prostaglandins E(2) and F(2α) that suppress subsequent adipogenesis program in cultured preadipocytes.
    Chowdhury AA; Rahman MS; Nishimura K; Jisaka M; Nagaya T; Ishikawa T; Shono F; Yokota K
    Prostaglandins Other Lipid Mediat; 2011 Aug; 95(1-4):53-62. PubMed ID: 21699992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dexmedetomidine inhibits LPS-induced inflammatory responses through peroxisome proliferator-activated receptor gamma (PPARγ) activation following binding to α
    Fujimoto M; Higuchi H; Honda-Wakasugi Y; Miyake S; Nishioka Y; Yabuki-Kawase A; Maeda S; Miyawaki T
    Eur J Pharmacol; 2021 Feb; 892():173733. PubMed ID: 33220278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The peroxisome proliferator-activated receptor gamma ligands, pioglitazone and 15-deoxy-Delta(12,14)-prostaglandin J(2), have antineoplastic effects against hepatitis B virus-associated hepatocellular carcinoma cells.
    Shim J; Kim BH; Kim YI; Kim KY; Hwangbo Y; Jang JY; Dong SH; Kim HJ; Chang YW; Chang R
    Int J Oncol; 2010 Jan; 36(1):223-31. PubMed ID: 19956851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.